It is important to note that PI3KI treatment of HNSCC cell lines resulted in transient but complete inhibition of phospho-AKT indicating that all the cells are sensitive to the PI3K inhibitory activity. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.